Disclosed are new polycyclic carbogenic molecules and their methods of synthesis. The new polycyclic carbogenic molecules may be utilized in anti-cancer therapies. In particular, the polycyclic carbogenic molecules may be formulated as pharmaceutical compositions that comprise the small molecules, which compositions may be administered in methods of treating and/or preventing cell proliferative diseases and disorders such as cancer. The new polycyclic carbogenic molecules may be prepared from vinyl- or allyl-substituted cyclohexenone precursors via preparation of a silyl bis-enol ether intermediate.
揭示了新的多环碳基分子及其合成方法。这些新的多环碳基分子可以用于抗癌疗法。特别是,这些多环碳基分子可以制成包含小分子的药物组合物,这些组合物可以在治疗和/或预防细胞增殖性疾病和癌症等疾病的方法中使用。这些新的多环碳基分子可以通过从
乙烯或烯丙基取代的
环己酮前体制备
硅烷双烯醚中间体来制备。